BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30298748)

  • 1. Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation.
    Jeong H; Kim JW; Yang MS; Park C; Kim JH; Lim CW; Kim B
    Am J Chin Med; 2018 Oct; ():1-27. PubMed ID: 30298748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Korean Red Ginseng on metabolic syndrome.
    Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT
    J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function.
    Hong JT; Lee MJ; Yoon SJ; Shin SP; Bang CS; Baik GH; Kim DJ; Youn GS; Shin MJ; Ham YL; Suk KT; Kim BS
    J Ginseng Res; 2021 Mar; 45(2):316-324. PubMed ID: 33841012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
    Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
    BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
    Hu J; Zheng Y; Ying H; Ma H; Li L; Zhao Y
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.
    Yang H; Deng Q; Ni T; Liu Y; Lu L; Dai H; Wang H; Yang W
    Int J Biol Sci; 2021; 17(15):4207-4222. PubMed ID: 34803493
    [No Abstract]   [Full Text] [Related]  

  • 8. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
    Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease.
    Kim JC; Jeon JY; Yang WS; Kim CH; Eom DW
    Curr Pharm Biotechnol; 2019; 20(3):222-231. PubMed ID: 30854954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 11. Korean Red Ginseng exerts anti-inflammatory and autophagy-promoting activities in aged mice.
    Kim JK; Shin KK; Kim H; Hong YH; Choi W; Kwak YS; Han CK; Hyun SH; Cho JY
    J Ginseng Res; 2021 Nov; 45(6):717-725. PubMed ID: 34764726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean red ginseng attenuates hyperglycemia-induced renal inflammation and fibrosis via accelerated autophagy and protects against diabetic kidney disease.
    Karunasagara S; Hong GL; Park SR; Lee NH; Jung DY; Kim TW; Jung JY
    J Ethnopharmacol; 2020 May; 254():112693. PubMed ID: 32112899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments.
    Hong YJ; Kim N; Lee K; Hee Sonn C; Eun Lee J; Tae Kim S; Ho Baeg I; Lee KM
    J Ethnopharmacol; 2012 Nov; 144(2):225-33. PubMed ID: 22925946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Seong E; Bose S; Han SY; Song EJ; Lee M; Nam YD; Kim H
    EPMA J; 2021 Jun; 12(2):177-197. PubMed ID: 34194584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of Jinan Red Ginseng and licorice extract mixtures ameliorates nonalcoholic steatohepatitis by modulating lipogenesis.
    Yang D; Jeong H; Hwang SM; Kim JW; Moon HW; Lee YE; Oh HB; Park CB; Kim B
    J Ginseng Res; 2022 Jan; 46(1):126-137. PubMed ID: 35058729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Korean Red Ginseng Protects Against Mitochondrial Damage and Intracellular Inflammation in an Animal Model of Type 2 Diabetes Mellitus.
    Park JK; Shim JY; Cho AR; Cho MR; Lee YJ
    J Med Food; 2018 Jun; 21(6):544-550. PubMed ID: 29708804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
    Cheng Y; Chen T; Ping J; Chen J
    Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-diabetic properties of different fractions of Korean red ginseng.
    Park SJ; Nam J; Ahn CW; Kim Y
    J Ethnopharmacol; 2019 May; 236():220-230. PubMed ID: 30849506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.